3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
24
Stomach Neoplasms
5
Rectal Neoplasms
5
Neoplasm Metastasis
5
Colonic Neoplasms
5
Carcinoma, Hepatocellular
4
Cholangiocarcinoma
3
Biliary Tract Neoplasms
3
Adenocarcinoma Of Esophagus
3
Unresectable Metastatic Colorectal Cancer
2
Recurrence
2
Neoplastic Cells, Circulating
2
Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Adenocarcinoma
2
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Ovarian Neoplasms
1
Oligometastatic Gastric Adenocarcinoma
1
Neoplasms, Second Primary
1
Neoplasm, Residual
1
Margins of Excision
1
Lung Neoplasms
1
Locally-advanced Rectal Cancer
1
Locally Advanced Colorectal Carcinoma
1
Hyperthermia
1
Gastroesophageal Junction Adenocarcinoma
1
Gastroesophageal Adenocarcinoma
1
Gallbladder Neoplasms
1
Interventions
Cyclophosphamide
7
venetoclax
6
Azacitidine
6
fludarabine
5
Cytarabine
4
Blood Specimen Collection
4
daratumumab
3
Lenalidomide
3
Daunorubicin
3
tislelizumab
2
fludarabine phosphate
2
Rituximab
2
Liquid Biopsy
2
Idarubicin
2
Gemtuzumab
2
Capecitabine
2
Busulfan
2
trastuzumab deruxtecan
1
thymoglobulin
1
tetrathiomolybdate
1
talquetamab
1
tagraxofusp
1
sugemalimab
1
sacituzumab govitecan
1
relugolix
1
pembrolizumab
1
pegaspargase
1
palbociclib
1
obinutuzumab
1
ivosidenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasm, Residual
×
Folfox protocol
×
Clear all
NCT05534087
2024-11-29
CLAUDIA
Seoul National University Hospital
Phase 3
Recruiting
236 enrolled